CAV2 and lung carcinoma: Taken together, our data suggest that host deficiency in Cav-2 causes tumor regression in two independent syngeneic models of lung cancer growth in immunocompetent mice involving s.c. injection of LLC and CMT 167 lung carcinoma cells.